The market continues to shrink and adjust, raising concerns about a retreat in the Siasun Robot&Automation Sector. Can the deep-sea Technology Concept hold the flag and launch a counterattack?

Track the entire lifecycle of the main Sector.

cls.cnMar 23 21:22 ET

Special Treat Jiahua is on the brink of being delisted, with losses of 4.3 billion over six years. How can it turn around while being mired in the mud of salmon farming?

① ST Jiawo will become the first company on the A-share market to receive a non-standard audit opinion in 2025. The company will also be subject to delisting risk warnings; ② The turning point in performance appeared in 2019, when the company acquired the salmon business through a significant investment; ③ The company previously went public through Wanfushengke, creating a classic case of "turnaround in adversity." Now faced with difficulties again, how will it turn around this time?

cls.cnMar 13 10:09 ET

Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the

① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.

cls.cnMar 2 21:09 ET

Retail channels are under pressure, and Yihai Kerry Arawana Holdings' performance last year declined by more than 10% year-on-year, planning to further extend the Industry Chain | Interpretations.

① The main products saw an increase in volume but a decrease in price, with Yihai Kerry Arawana Holdings' revenue and Net income both declining year-on-year in 2024; ② The company established a subsidiary with Jiangxi Fushine Pharmaceutical, with company personnel stating that this move aims to extend the Industry Chain and enrich downstream products.

cls.cnFeb 20 08:28 ET

Is the low sugar price dragging down? Cofco Sugar Holding's net income in Q3 decreased by more than 50% year-on-year | Interpretations

①Cofco Sugar Holding achieved revenue of 7.757 billion yuan in Q3, a year-on-year decrease of 30.41%, achieving a net income of 0.299 billion yuan, a year-on-year decrease of 55.41%; ② The company's revenue and net income have experienced consecutive year-on-year declines for two quarters, and the year-on-year decline is expanding.

cls.cnOct 22, 2024 10:36 ET

"Oily grass" yihai kerry arawana holdings net profit in the first half of the year halved, now less than 1 billion, non-net profit decreased by 99.40% | Financial Report Insights

Formerly known as 'Youmao', yihai kerry arawana holdings seems to be caught in a profit dilemma, with a year-on-year decrease of 51.13% in net income in the first half of the year, and a significant year-on-year decrease of 99.40% in non-net profit. On the afternoon of August 11th, yihai kerry arawana holdings announced its 2023 interim report. As of June 30, yihai kerry arawana holdings' revenue was 118.714 billion yuan, a year-on-year decrease of 0.64%; net income attributable to shareholders of the listed company was 0.966 billion yuan, a year-on-year decrease of 51.13%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 14.427 million yuan, a year-on-year decrease of 99.40%; basic earnings per share was 0.18 yuan, compared to

Wallstreet NewsAug 11, 2023 08:03 ET